New on this website

27.01.2023

Announcements on clinical trials with medical devices

MDCG 2020-10 rev. 1 – The guidance document and table for safety reporting during clinical investigations have been updated.

27.01.2023

Jurist/in (80-100%)

Job advertisement | Abteilung Rechtsdienst Medizinprodukte

27.01.2023

Jurist/in (80-100%)

Job advertisement | Abteilung Rechtsdienst Arzneimittel

27.01.2023

Leiter/in Bereich Zulassung

Job advertisement | Mitglied der Geschäftsleitung

27.01.2023

Public Summary SwissPAR – Rapibloc®

First authorisation

26.01.2023

Swissmedic and the UK Veterinary Medicines Directorate agree collaboration on veterinary medicinal products

Raimund Bruhin (Executive Director, Swissmedic) and Gavin Hall (Deputy CEO, Veterinary Medicines Directorate) have signed a Memorandum of Understanding on collaboration in the area of veterinary medicinal products.

26.01.2023

Out-of-Stock – LiDCO Lithiumchlorid 0.15 mmol/ml, Injektionslösung

Befristete Bewilligung zum Vertrieb in tschechischer Aufmachung

25.01.2023

Clinical Pharmacology Assessor (80-100%)

Job advertisement | Division Clinical Assessment

25.01.2023

Assistenten/in (60-80 %)

Job advertisement | Abteilung Komplementär- und Phytoarzneimittel

23.01.2023

Validity of GMP certificates during the COVID-19 pandemic

Update of the validity period of EMA GMP certificates

20.01.2023

Strategic objectives 2023–2026

The strategy for 2023-2026 was developed with recognised strategy development methods that have demonstrated their usefulness in practice.
Permanent link of this page
www.swissmedic.ch/updates-en
News channel of this page

Last modification 13.02.2020

Top of page